FDA Adverse Event Injury Summary report: N

EGIA 60 ARTICULATING MED/THICK SULU

MDR report key: 2892204 · Received December 21, 2012

Report

Report Number
1219930-2012-01005
Event Type
Injury
Date Received
December 21, 2012
Date of Event
October 11, 2012
Report Date
November 27, 2012
Manufacturer
COVIDIEN LP, FORMERLY REGISTERED AS UNITED STATES
Product Code
GDW
PMA / PMN Number
K083519
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
RISK MANAGER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

PROCEDURE TYPE: LAPAROSCOPIC GASTRIC BYPASS. ACCORDING TO THE REPORTER: STAPLE LINES WERE INSPECTED AND FOUND TO BE HEMOSTATIC ON (B)(6) 2012. ON (B)(6) 2012 THE PATIENT HAD TO BE RETURNED TO THE OPERATING ROOM DUE TO BLEEDING OVER THE STAPLE LINE THAT REQUIRED OVERSEWING. THE PATIENT REQUIRED AN ICU ADMISSION POST-OPERATIVELY AND SUSTAINED A RISE IN CREATINE LIKELY RELATED TO BLOOD LOSS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 EGIA 60 ARTICULATING MED/THICK SULU NONE GDW COVIDIEN LP, FORMERLY REGISTERED AS UNITED STATES N2E0753ULX

Patients

Seq Age Sex Outcome Treatment
1 52 YR Hospitalization| O